| 标题 |
[Effectiveness and safety of atezolizumab plus bevacizumab versus lenvatinib in patients with unresectable HBV-related hepatocellular carcinoma] |
| 网址 | |
| DOI |
10.3760/cma.j.cn112137-20250803-01952
doi
|
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)